Towards the integration of treatment systems for substance abusers: Report on the second international symposium on substance abuse treatment and special target groups

Journal of Psychoactive Drugs

Volumn 35, Issue 2, 2003, Pages 237-245

  Broekaert, Eric ^a   Vanderplasschen, Wouter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Harm reduction; Integrated treatment systems; Managed care; Substance abuse treatment; Therapeutic communities

Indexed keywords

METHADONE;

ABSTINENCE; CONFERENCE PAPER; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MANAGED CARE; SUBSTANCE ABUSE;

EID: 0042166076     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2003.10400005     Document Type: Article

References (87)

1. Acampora, A. & Stern, C. 1994. The evolution of the therapeutic community. In: Therapeutic Communities of America (Ed.) Therapeutic Communities of America. Treatment Paradigms: Past, Present and Future. Proceedings of the 1992 National Planning Conference. Washington, D.C.: Therapeutic Communities of America Publications.
2. Arizona Department of Health Services. 2001. Arizona Integrated Treatment Consensus Panel Home Page. Available at: www.hs.state.az.us/bhs/home.htm.
3. Bachmann, K.M.; Moggi, F.; Hirsbrunner, H.P.; Donati, R. & Brodbeck, J. 1997. An integrated treatment program for dually diagnosed patients. Psychiatric Services 48 (3): 314-16.
4. Balian, R. & White, C. 1998. Defining the Drug User. New York: A. Greig. Available at: www.harmreduction.org/news/news/fa1198.
5. Bammer, G. & Gerrard, G. (Eds.) 1992. Heroin Treatment: New Alternatives. Proceedings of a Seminar Held on I November 1991. Canberra, Australia: The Australian National University, National Centre for Epidemiology and Population Health.
6. Bassin, A. 1977. The miracle of the TC from birth to post-partum insanity to full recovery. Second World Conference of Therapeutic Communities, McGill University, Montreal/Canada. (Copies available at Florida State University, Tallahassee.)
7. Bratter, T.E. & Forrest, G. (Eds.) 1985. Alcoholism and Substance Abuse: Strategies for Clinical Intervention. New York: Free Press MacMillan.
8. Bratter, T.E. 1978. The negative self-fulfilling prophecy of methadone maintenance. Corrective and Social Psychiatry 24 (1): 1-5.
9. Broekaert, E. & Slater, A. 2001. The development of the therapeutic community in Western and Southern Europe. European Federation of Therapeutic Communities Newsletter 7: 16-20.
10. Broekaert, E.; Vanderplasschen, W. & Bradt, H. (Eds.) 2000. Proceedings of the Second International Symposium on Substance Abuse Treatment and Special Target Groups. The Integration of Different Treatment Models. Ghent, Belgium: Ghent University, Department of Orthopedagogics & E.F.T.C. (European Federation of Therapeutic Communities).
11. Broekaert, E.; Vanderplasschen, W.; Temmerman, I.; Ottenberg, D.J. & Kaplan, C. 2000. Retrospective study of similarities and relations between American drug-free and European therapeutic communities for children and adults. Journal of Psychoactive Drugs 32 (4): 407-17.
12. Broekaert, E.; van der Straten, G.; d'Oosterlinck, F. & Kooyman, M. 1999. The therapeutic community for ex-addicts: A view from Europe. Therapeutic Communities: The International Journal for Therapeutic and Supportive Organizations 20 (4): 255-66.
13. Broekaert, E. & van der Straten, G. 1997. Histoire, philosophic et développement de la communauté thérapeutique en Europe. Psychotropes: Revue Internationale des Toxicomanies 3 (1): 7-23.
14. Brook, R.; McGlynn, E. & Shekelle, P. 2000. Defining and measuring the quality of care: A perspective from U.S.-researchers. International Journal for Quality in Health Care 12 (4): 281-95.
15. Däumling, M. 2000. Integration of different treatment models in the concept of treatment of drug-addicts of the Deutche Orden. In: E. Broekaert; W. Vanderplasschen & H. Bradt (Eds.) Proceedings of the Second International Symposium on Substance Abuse Treatment and Special Target Groups. The Integration of Different Treatment Models. Ghent, Belgium: Ghent University, Department of Orthopedagogics & E.F.T.C. (European Federation of Therapeutic Communities).
16. Deitch, D. & Zweben, J. 1979. Synanon: A pioneering response in drug abuse treatment and a signal forcaution. In: H. Seymour & L. Bambe (Eds.) Proceedings of the Fourth World Conference of Therapeutic Communities. New York: Daytop Village-I.C.A.A.
17. De Leon, G. 1997a. Passages: A therapeutic community oriented day treatment model for methadone maintained clients. Journal of Drug Issues 27 (2): 341-42.
18. De Leon, G. 1997b. Community as a Method: Therapeutic Communities for Special Populations and Special Settings. Westport, Connecticut: Praeger Publishers.
19. De Leon, G. 1996. Integrative recovery: A stage paradigm. Substance Abuse 17 (I): 51-63.
20. Denning, P. 2001. Strategies for implementation of harm reduction in treatment settings. Journal of Psychoactive Drugs 33 (I): 23-26.
21. Derks, J. 1990. The efficacy of the Amsterdam morphine-dispensing program. In: H.A. Ghodse; C.D. Kaplan & R.D. Mann (Eds.) Drug Misuse and Dependence. Park Ridge, New York: Parthenon.
22. Des Jarlais, D.C.; Friedman, S.R.; Sotheran, J.L.; Wenston, J.; Marmor, M.; Yancovitz, S.R.; Frank, B.; Beatrice, S. & Mildvan, D. 1994. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. Journal of the American Medical Association 271 (2): 121-27.
23. de Weert-Van Oene, G. & Schrijvers, A. 1992. Van Lappendeken naar Zorgcircuit: Circuitvorming in de Utrechtse Verslavingszorg. Utrecht, the Netherlands: Rijksuniversiteit Utrecht, Vakgroep Algemene gezondheidszorg en epidemiologie.
24. Drake, R.E.; Mercer-McFadden, C; Mueser, K.T.; McHugo, G.J. & Bond, G.R. 1998. Review of integrated mental health and substance abuse. Schizophrenia Bulletin 24 (4): 589-608.
25. Drake, R.E.; Yovetich, N.A.; Bebout, R.R.; Harris, M. & Mchugo, G.J. 1997. Integrated treatment for dually diagnosed homeless adults. Journal of Nervous and Mental Disease 185 (5): 298-305.
26. Drucker, E. 1995. Harm reduction: A public health strategy. Current Issues in Public Health 1: 64-70.
27. European Monitoring Centre for Drugs and Drug Addiction (EMCDOA). 2001. Annual Report on the State of the Drugs Problem in the European Union. Luxembourg: Office for Official Publications of the European Communities.
28. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 1999. Annual Report on the State of the Drugs Problem in the European Union. Luxembourg: Office for Official Publications of the European Communities.
29. Ezard, N.; Lintzeris, N.; Odgers, P.; Koutroulis, G.; Muhleisen, P.; Stowe, A. & Lanagan, A. 1999. An evaluation of community methadone services in Victoria, Australia: results of a client survey. Drug and Alcohol Review 18 (4): 417-23.
30. Fiorentine, R. & Hillhouse, P. 2000. Drug treatment and 12-Step program participation. The additive effects of integrated recovery activities. Journal of Substance Abuse Treatment 18 (1): 65-74.
31. Fridell, M. 1999. Evaluating residential and institutional treatment. In: European Monitoring Centre for Drugs and Drug Addiction (Eds.). Evaluating the Treatment of Drug Abuse in European Union. EMCDDA Scientific Monograph Series No. 3. Luxembourg: Office for Official Publications of the European Communities.
32. Friedmann, P.; D'Aunno, T.; Jin, L. & Alexander, J. 2000 Medical and psychosocial services in drug abuse treatment: Do stronger linkages promote client utilization? Health Services Research 35 (2): 443-65.
33. Glaser, F. 1977. The Origins of the Drug-Free Therapeutic Community: A Retrospective History. Toronto, Canada: Addiction Research Foundation.
34. Gleghorn, A.; Rosenbaum, M. & Garcia, B.A. 2001. Editor's introduction: Bridging the gap in San Francisco, the process of integrating harm reduction and traditional substance abuse services. Journal of Psychoactive Drugs 33 (1): 1-7.
35. Goransson, B. 1997. Treatment and rehabilitation in Sweden. Integration of national policy at community level. In: S. Sollbakken (Ed.) Proceedings from the Third European Conference on Rehabilitation and Drug Policy. Oslo, Norway: Norwegian Directory for the Prevention of Alcohol and Drug Problems.
36. Gould, F.; Levine, M. & McLellan, A.T. 2000. Treating the substance-abusing patient in the public sector: "Medical necessity” versus "social necessity and social responsibility” in the Philadelphia Target Cities demonstration project. Journal of Substance Abuse Treatment 18 (1): 75-77.
37. Graham, K.; Timney, C.; Bois, C. & Wedgerfield, K. 1995. Continuity of care in addictions treatment: The role of advocacy and coordination in case management. American Journal of Drug and Alcohol Abuse 21 (4): 433-51.
38. Grella, C.E. 1996. Background and overview of mental health and substance abuse treatment systems: Meeting the needs of women who are pregnant or parenting. Journal of Psychoactive Drugs 28 (4): 319-43.
39. Griffin, S. 2001. Do No Harm. San Diego, California: Griffen & Wong Institute. Available at: www.Realsolutions.org/donoharrn.htm.
40. Hagedorn, J. 1998. The business ofdrugdealing in Milwaukee. Thiensville Wisconsin Policy Research Institute 11 (5): 1-33.
41. Harm Reduction Coalition (HRC). 2001 Principles of Harm Reduction: The Need for Harm Reduction. New York: HRC. Available at: www.harmreduction.org/prince.html.
42. Hartel, O.M.; Schoenbaum, E.E.; Selwyn, P.A.; Kline, J.; Oavenny, K.; Klein, R.S. & Friedland, G.H. 1995. Heroin use during methadone-maintenance: The importance of methadone dose and cocaine use. American Journal of Public Health 85 (1): 83-88.
43. Hartgers, C.; Buning, E.C.; van Santen, G.W.; Verster, A.D. & Coutinho, R.A. 1998. The impact of the needle and syringe exchange programme in Amsterdam on injecting risk behaviour. AIDS 3 (9): 571-76.
44. Hellerstein, O.J.; Rosenthal, R.N. & Miner, C.R. 2001. Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly 72 (4): 291-306.
45. Hser, Y. 1995. A referral system that matches drug users to treatment programs: Existing research and relevant issues. Journal of Drug Issues 25 (1), 209-24.
46. Inciardi, J. 1999. The Drug Legalization Debate. Thousand Oaks, California: Sage Publications.
47. Kersten, T.; Schippers, G.; Broekman, T.; van Rijswijk, A. & Joosten, A. 1995. Ontwikkeling en Verbetering vn Indicatiestelling en Verwijzing van Clienten met Verslavingsproblematiek. Nijmegen, the Netherlands: Bureau Beta.
48. Klingemann, H.K.H. 1996. Drug treatment in Switzerland: Harm reduction, decentralization and community response. Addiction 91 (5): 723-36.
49. Koller, E. 1999. The policy-maker’s perspective. In: European Monitoring Centre for Drugsand Drug Addiction. (Ed.) Evaluating the Treatment of Drug Abuse in the European Union. EMCDDA Scientific Monograph Series No. 3. Luxembourg: Office for Official Publications of the European Communities.
50. Kooyman, M. 2001. The history of therapeutic communities. A view from Europe. In: B. Rawlings & R. Yates (Eds.) Therapeutic Communities for the Treatment of Drug Users. London: Jessica Kingsley Publishers.
51. Kooyman, M. 1993. The Therapeutic Community forAddicts: Intimacy, Parent Involvement and Treatment Success. Amsterdam: Swets & Zeitlinger.
52. Korf, D. 1990. Cannabis retail markets in Amsterdam. International Journal of Drug Policy 2 (1): 23-27.
53. KUng, M. 1997. Drug prevention in the light of a changing drug policy. In: S. Sollbakken (Ed.) Proceedings from the Third European Conference on Rehabilitation and Drug Policy. Oslo, Norway: Norwegian Directorate for the Prevention of Alcohol and Drugs Problems.
54. Lennard, H.I.; Epstein, L.J. & Rosenthal, M.S. 1972. The methadone illusion. Science 176 (37): 881-84.
55. Marlatt, G.A.; Blume, A. & Parks, G. 2001. Integrating harm reduction therapy and traditional substance abuse treatment. Journal of Psychoactive Drugs 33 (1): 13-22.
56. Marset, M. 1999. Programmes of controlled prescription ofheroin: Drug addict integration into a process of change. In: C. Hernandes Gil (Ed.) Proceedings of the Fourth European Conference on Rehabilitation and Drug Policy. Marbella, Spain: Spanish National Plan on Drugs.
57. Martin, P. 1999. Flexibility in treatment provisions. Programs of controlled prescription of heroine: Drug addict integration into a process of change. In: C. Hernandes Gil (Ed.) Proceedings of the Fourth European Conference on Rehabilitation and Drug Policy. Marbella, Spain: Spanish National Plan on Drugs.
58. Mitchell, O.; Mitchell, C. & Ofshe, R. 1980. The Light on Synanon. New York: Seaview Books.
59. Mowrer, O.H. 1976. Therapeutic groups and communities in retrospect and prospect. Paper presented at the First World Conference on Therapeutic Communities, Vallmotorp Foundation, Katrineholm, Sweden.
60. Nation's Voice on Mental Illness (NAMI). 2001. Integrated Treatment and Blended Funding for Co-Occurring Mental and Addictive Disorders. Arlington: NAMI. Available at: www.nami.org/update/unitedintegrate.html.
61. Newman, R.G. 1990. Advocacy for methadone treatment. Annals of Internal Medicine 113 (11): 819-20.
62. Newman, R.G. 1985. Narcotic addiction and methadone treatment in Hong Kong: Lessons forthe United States. Jourrnal of Public Health Policy [Southeast Asian Edition] 6 (4): 526-38.
63. O'Brien, W.B. 1993. You Can’t Do It Alone. New York: Simon and Schuster.
64. Office of the Chief Medical Officer. 1994. AIDS Prevention Statistics on Needle Exchange 19921-1993. Zurich: Health Department of the City of Zurich.
65. Ottenberg, D.J. 2000. Conclusions of the plenary meeting and workshops. In: E. Broekaert; W. Vanderplasschen & H. Bradt (Eds.) Proceedings of the Second International Symposium on Substance Abuse Treatment and Special Target Groups. The Integration of Different Treatment Models. Ghent, Belgium: Ghent University, Department of Orthopedagogics & E.F.T.C. (European Federation of Therapeutic Communities).
66. Ottenberg, D.J. 1984. Therapeutic community and the danger of the cult phenomena. In: L. Bremberg (Ed). Proceedings of the First World Conference on Therapeutic Communities. Katrineholm, Sweden: Vallmotorp Foundation.
67. Rohrer, J.; Vaughan, M.; Cadoret, R.; Carswell, C.; Patterson, A. & Zwick, J. 1996. Effect of centralized intake on outcomes of substance abuse treatment. Psychiatric Services 47 (11): 1233-38.
68. Rosenbaum, M. 1996. Kids, Drugs, and Drug Education: A Harm Reduction Approach. San Francisco, California: The National Council on Crime and Delinquency.
69. Rucker, R. 1986. Oneindigheid, Filosofie en Wetenschap van het Oneindige. Amsterdam: Contact.
70. Sciacca, K. 1991. An integrated treatment approach for severely mentally ill individuals with substance disorders. In: K. Minkoff & R. Drake (Eds.) New Directions for Mental Health Services, No. 50. Dual Diagnosis of Major Mental Illness and Substance Disorder. San Francisco, California: Jossey-Bass Publishers.
71. Sciacca, K. & Thompson, C.M. 1996. Program development and integrated treatment across systems for dual diagnosis: Mental illness, drug addiction and alcoholism (MIDAA). Journal of Mental Health Administration 23 (3): 288-97.
72. Siegal, H. 1998. Comprehensive Case Management for Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series 27. Rockville, Maryland: US Department of Health and Human Services, Center for Substance Abuse Treatment.
73. Smith, D. & Luce, J. 1969. Love Needs Care: A History of the Haight-Ashbury Free Medical Clinic. Boston, Toronto: Little, Brown and Company.
74. Stimson, G.V. & Oppenheimer, E. 1982. Heroin Addiction: Treatment and Control in Britain. London: Tavistock.
75. Tomlinson, D. 1994. President's message. [Newsletter] In: P. Zafiridis (Ed.) European Federation of Therapeutic Communities. Athens: Kethea.
76. Turnbull, P.J. & Webster, R. 1998. Demand reduction activities in the criminal justice system in the European Union. Drugs: Education, Prevention and Policy 5 (2): 177-84.
77. Uchtenhagen, A. 1997. Maintenance treatment. In: S. Sollbakken (Ed.) Proceedings from the Third European Conference on Rehabilitation and Drug Policy. Oslo, Norway: Norwegian Directorat for the Prevention of Alcohol and Drugs Problems.
78. Van der Meer, C. 1997. Inpatient treatment and update. In: S. Sollbakken (Ed.) Proceedings from the Third European Conference on Rehabilitation and Drug Policy. Oslo, Norway: Norvegian Directorat for the Prevention of Alcohol and Drug Problems.
79. Vanderplasschen, W. & Broekaert, E. 2000. Using case management to reduce harm among substance abusers with multiple and complex problems. In: International Harm Reduction Association (Ed.) Program & Abstract Book of the 11th International Conference on the Reduction of Drug Related Harm. Jersey, Channel Islands: International Harm Reduction Association.
80. Vanderplasschen, W.; De Bourdeaudhuij, I. & Van Oost, P. 2002. Coordination and continuity of care in substance abuse treatment: an evaluation study in Belgium. European Addiction Research 8: 1021
81. Vanderplasschen, W.; Lievens, K. & Broekaert, E. 2001. "‘Drug treatment tourism” in specialised treatment facilities. In: International Council on Alcohol and Addictions (Ed.) Programme andAbstract Book of the 44th International ICAA Conference on the Prevention and Treatment of Dependencies “Science Meets Practice ". Heidelberg, Germany: International Council on Alcohol and Addictions.
82. Vanderplasschen, W.; Mostien, B.; Claeys, P.; Raes, V. & Van Bouchaute, J. 2001 Conceptnota Organisatiemodel Zorgcircuit Middelenmisbruik. Orthopedagogische Reeks 12. Ghent, Belgium: Ghent University, Department of Orthopedagogics.
83. VOCA Training & Consult. 1998. Totaal Kwaliteitsmanagement: Handleiding voor het Systematisch Werken aan Kwaliteit in Gezondheids- en Welzijnsvoorzieningen. Garant: Leuven-Appeldoom.
84. Weisner, C.; Mertens, J; Parthasarathy, S.; Moore, C. & Lu, Y. 2001. Integrating primary medical care with addiction treatment. Journal of the American Medical Association 286 (14): 1715-23.
85. Yablonsky, L. 1965. Synanon: The Tunnel Back. Baltimore, Maryland: Penguin Books.
86. Zarkin, G.A. & Dunlap, L.J. 1999. Implications of managed care for methadone treatment. Findings from five case studies in New York State. Journal of Substance Abuse Treatment 17 (1-2): 25-35.
87. Zimmerman, D. 1999. Scientism and managed care: The betrayal of group and individual treatment for children. Therapeutic Communities 20 (4): 281-300.